An Analysis Of Oragenics Inc. (OGEN) Stock

view original post

Oragenics Inc. (AMEX:OGEN) has a beta value of -0.01 and has seen 1.11 million shares traded in the last trading session. The company, currently valued at $61.16M, closed the last trade at $0.52 per share which meant it lost -$0.01 on the day or -0.48% during that session. The OGEN stock price is -246.15% off its 52-week high price of $1.80 and 17.31% above the 52-week low of $0.43. The 3-month trading volume is 3.42 million shares.

The consensus among analysts is that Oragenics Inc. (OGEN) is a Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -$0.04.

3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Sporting -0.48% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, 01/07/22 when the OGEN stock price touched $0.52 or saw a rise of 11.85%. Year-to-date, Oragenics Inc. shares have moved 17.42%, while the 5-day performance has seen it change 17.42%. Over the past 30 days, the shares of Oragenics Inc. (AMEX:OGEN) have changed 5.80%.

Wall Street analysts have a consensus price target for the stock at $2.50, which means that the shares’ value could jump 79.2% from current levels. The projected low price target is $2.50 while the price target rests at a high of $2.50. In that case, then, we find that the current price level is -380.77% off the targeted high while a plunge would see the stock gain -380.77% from current levels.

Oragenics Inc. (OGEN) estimates and forecasts

The company’s shares have lost -17.20% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 32.10% over the past 5 years.

OGEN Dividends

Oragenics Inc. is expected to release its next earnings report on August 16 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Oragenics Inc. (AMEX:OGEN)’s Major holders

Insiders own 1.48% of the company shares, while shares held by institutions stand at 9.23% with a share float percentage of 9.37%. Investors are also buoyed by the number of investors in a company, with Oragenics Inc. having a total of 28 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 5.05 million shares worth more than $3.21 million. As of Sep 29, 2021, Vanguard Group, Inc. (The) held 4.34% of shares outstanding.

The other major institutional holder is Blackrock Inc., with the holding of over 1.31 million shares as of Sep 29, 2021. The firm’s total holdings are worth over $0.83 million and represent 1.12% of shares outstanding.

>> 7 Top Picks for the Post-Pandemic Economy <<

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Sep 29, 2021, the former fund manager holds about 3.06% shares in the company for having 3.56 million shares of worth $2.26 million while later fund manager owns 1.33 million shares of worth $0.84 million as of Sep 29, 2021, which makes it owner of about 1.14% of company’s outstanding stock.